South Korean researchers develop AI model for `customised` cancer vaccine
A joint research team of the Korea Advanced Institute of Science and Technology (KAIST) and domestic biotechnology firm Neogenlogic has developed a new artificial intelligence (AI) model that can help produce a whole new type of "personalised" cancer vaccine, the joint team said on Friday.
The new AI platform helps identify neoantigens unique to each cancer patient that can train the patient`s immune system, and thus prevent recurrence of the illness, reports Yonhap news agency.
"Neoantigens -- mutation-derived protein fragments unique to a patient`s tumor -- are the `fingerprints` used by vaccines to train the immune system," the team, led by professor Choi Jung-kyoon of KAIST, said in a press release.
"While current vaccines focus almost exclusively on activating cytotoxic T cells fo...










